338874 <common-name>(5z)-5-(5-bromo-2-oxo-1-propylindol-3-ylidene)-3-[2-(3,4-dimethoxyphenyl)ethyl]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-5-(5-bromo-2-oxo-1-propylindol-3-ylidene)-3-[2-(3,4-dimethoxyphenyl)ethyl]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C24H23BrN2O4S2. With an average molecular weight of 547.50 g/mol, (5z)-5-(5-bromo-2-oxo-1-propylindol-3-ylidene)-3-[2-(3,4-dimethoxyphenyl)ethyl]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>617696-63-6</cas> <pubchem-id>5841887</pubchem-id> <chemical-formula>C24H23BrN2O4S2</chemical-formula> <weight>547.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T22:02:19Z</created-at> <updated-at type="dateTime">2026-08-30T22:02:19Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCN1C2=C(C=C(C=C2)Br)C(=C3C(=O)N(C(=S)S3)CCC4=CC(=C(C=C4)OC)OC)C1=O</moldb-smiles> <moldb-formula>C24H23BrN2O4S2</moldb-formula> <moldb-inchi>InChI=1S/C24H23BrN2O4S2/c1-4-10-26-17-7-6-15(25)13-16(17)20(22(26)28)21-23(29)27(24(32)33-21)11-9-14-5-8-18(30-2)19(12-14)31-3/h5-8,12-13H,4,9-11H2,1-3H3/b21-20-</moldb-inchi> <moldb-inchikey>MXDKWNKHDROHJV-MRCUWXFGSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">546.02826</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM334767</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-5-(5-bromo-2-oxo-1-propylindol-3-ylidene)-3-[2-(3,4-dimethoxyphenyl)ethyl]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Methoxybenzenes</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0289300</sync-id> <structure-inchikey>MXDKWNKHDROHJV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>800240800000000800000000000000000000000000400000004002000220000000008000000000000000000000000000000000000000000000000001000000080000000000000020000010000100000000800000000200000020001008000040000000110000000400000100000000000000000000001000000040000000000000000000004044000000000000000000001400000080000100004000400000000000080000000000000020000000000000000000000080100000000000200000000100800000000000040000040000000220000000000200000000000000000040000000801200000000000030000100000000000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJAAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBwAoAAAAAwMGQCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEjACAAAAABBgAoAAAAAwQGACgAAAAD BAYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYAKAAAAAMEEAAoAAAAAwIQACAA AAACBgBgAAAAAgIGAGAAAAACAgZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQG QCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAQMIACgA AAADAgYAYAAAAAEDBgAoAAAAAwQIACgAAAADAgsAAQABAgACAwADBCAEBWgM BQZoDAYHaAwHCGgMCAloDAcKAAULIAsMKAIMDSANDigCDQ8gDxAgEBEoAhAS AA8TABMUABQVABUWaAwWF2gMFxhoDBgZaAwZGmgMGBsgGxwAFx0gHR4ACx8g HyAoAh8DIAkEaAwSDAAaFWgMQgQAAAAFAwQFCx8GBgcICQQFBQ0MEhAPBhYX GBkaFRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:39:31Z</structure-indexed-at> </compound>